$TESI
Titan Environmental Solutions Inc Stock $tesi

$tesi Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223036485 Filed on October 06, 2023

Income Statement

Concept	2023 Q4	2023 Q2	2022 Q4
Revenue	$2.056M	$184.2K	$1.580K
YoY Change	130049.37%	-54.92%	-99.74%
Cost Of Revenue	$1.799M	$1.544M	$54.21K
YoY Change	3219.22%	312.98%	-89.95%
Gross Profit	$257.0K	$85.59K	-$52.63K
YoY Change	-588.33%	146.63%	-182.22%
Gross Profit Margin	12.5%	46.47%	-3331.01%
Selling, General & Admin	$1.949M	$7.030M	$1.307M
YoY Change	49.18%	1527.12%	-5.89%
% of Gross Profit	758.52%	8213.67%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$147.9K	$241.7K	$22.87K
YoY Change	546.7%	882.78%	-3.58%
% of Gross Profit	57.55%	282.36%
Operating Expenses	$1.780M	$7.271M	$1.340M
YoY Change	32.83%	1492.43%	-5.12%
Operating Profit	-$1.523M	-$6.988M	-$1.393M
YoY Change	9.36%	1556.3%	3.29%
Interest Expense	-$695.0K	-$349.5K	-$2.762M
YoY Change	-74.84%	-48.29%	245.04%
% of Operating Profit
Other Income/Expense, Net	-$28.26K	-$15.92M	$0.00
YoY Change		2339.06%	-100.0%
Pretax Income	-$6.849M	-$22.90M	-$2.402M
YoY Change	185.16%	2031.68%	105.88%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$7.924M	-$22.90M	-$9.172M
YoY Change	-13.6%	2023.12%	684.28%
Net Earnings / Revenue	-385.35%	-12436.02%	-580478.48%
Basic Earnings Per Share		-$0.67
Diluted Earnings Per Share	-$0.52	-$0.67	-$2.07
COMMON SHARES
Basic Shares Outstanding	15.13M shares	33.94M shares	4.489M shares
Diluted Shares Outstanding		33.96M shares

Balance Sheet

Concept	2023 Q4	2023 Q2	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$103.6K		$1.310K
YoY Change	7806.87%		-97.67%
Cash & Equivalents	$103.6K	$236.8K	$1.312K
Short-Term Investments
Other Short-Term Assets	$248.9K		$45.43K
YoY Change	447.89%		-69.77%
Inventory	$145.0K	$455.1K
Prepaid Expenses
Receivables	$970.6K	$885.6K
Other Receivables	$7.350K		$0.00
Total Short-Term Assets	$1.475M	$1.783M	$66.46K
YoY Change	2120.12%	64.27%	-93.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.781M	$5.627M
YoY Change		10299.29%
Goodwill	$6.517M	$6.651M
YoY Change		13.43%
Intangibles	$6.654M	$11.19M	$0.00
YoY Change		872.64%	-100.0%
Long-Term Investments
YoY Change
Other Assets	$165.7K	$8.251K
YoY Change		-96.17%
Total Long-Term Assets	$20.70M	$25.20M
YoY Change		227.25%
TOTAL ASSETS
Total Short-Term Assets	$1.475M	$1.783M	$66.46K
Total Long-Term Assets	$20.70M	$25.20M
Total Assets	$22.18M	$26.98M	$66.46K
YoY Change	33266.65%	207.11%	-99.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.476M		$226.2K
YoY Change	1436.64%		-89.46%
Accrued Expenses	$979.5K		$24.22K
YoY Change	3944.3%		-94.3%
Deferred Revenue
YoY Change
Short-Term Debt	$2.872M		$0.00
YoY Change			-100.0%
Long-Term Debt Due	$3.911M		$751.9K
YoY Change	420.22%		243.37%
Total Short-Term Liabilities	$12.41M	$10.89M	$1.683M
YoY Change	637.56%	-1.52%	-84.46%
LONG-TERM LIABILITIES
Long-Term Debt	$3.175M
YoY Change
Other Long-Term Liabilities	$1.291M		$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$4.466M	$3.977M
YoY Change		603.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.41M	$10.89M	$1.683M
Total Long-Term Liabilities	$4.466M	$3.977M
Total Liabilities	$16.88M	$14.87M	$1.683M
YoY Change	902.95%	27.91%	-84.66%
SHAREHOLDERS EQUITY
Retained Earnings	-$150.1M	-$23.57M	-$17.52M
YoY Change	756.49%	115.24%	95.7%
Common Stock	$1.513K	$3.425K	$1.810K
YoY Change	-16.41%	664.51%	334.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.299M	$12.11M	-$1.616M
YoY Change
Total Liabilities & Shareholders Equity	$22.18M	$26.98M	$66.46K
YoY Change	33266.65%	207.11%	-99.22%

Cashflow Statement

Concept	2023 Q4	2023 Q2	2022 Q4
OPERATING ACTIVITIES
Net Income	-$7.924M	-$22.90M	-$9.172M
YoY Change	-13.6%	2023.12%	684.28%
Depreciation, Depletion And Amortization	$147.9K	$241.7K	$22.87K
YoY Change	546.7%	882.78%	-3.58%
Cash From Operating Activities	-$1.095M	-$573.0K	-$416.8K
YoY Change	162.71%	67.86%	-70.76%
INVESTING ACTIVITIES
Capital Expenditures	$483.8K	$173.6K	$320.00
YoY Change	151093.75%	-3162.26%	-111.15%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$219.1K	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$483.8K	$45.48K	-$320.00
YoY Change	151093.75%	-902.12%	-89.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.084M	599.5K	250.9K
YoY Change	332.06%	137.56%	-76.85%
NET CHANGE
Cash From Operating Activities	-1.095M	-573.0K	-416.8K
Cash From Investing Activities	-483.8K	45.48K	-320.0
Cash From Financing Activities	1.084M	599.5K	250.9K
Net Change In Cash	-494.8K	71.91K	-166.3K
YoY Change	197.63%	-175.93%	-51.73%
FREE CASH FLOW
Cash From Operating Activities	-$1.095M	-$573.0K	-$416.8K
Capital Expenditures	$483.8K	$173.6K	$320.00
Free Cash Flow	-$1.579M	-$746.7K	-$417.2K
YoY Change	278.49%	122.42%	-70.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001514056
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q2	TRIQ	Member Equity MemberEquity		usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization		usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization		usd
	TRIQ	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability		usd
CY2022Q2	TRIQ	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability		usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
	TRIQ	Employee Retention Credit EmployeeRetentionCredit		usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense		usd
	TRIQ	Change In Fair Value Of Derivative Liability And Derivative Expense ChangeInFairValueOfDerivativeLiabilityAndDerivativeExpense		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables		usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets		usd
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits		usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	TRIQ	Repayments Of Note Payables Related Parties RepaymentsOfNotePayablesRelatedParties		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	TRIQ	Noncash Transactions Related To Reverse Acquisition NoncashTransactionsRelatedToReverseAcquisition		usd
	TRIQ	Settlement Of Note Payable SettlementOfNotePayable		usd
CY2023Q2	TRIQ	Subscription Receivable SubscriptionReceivable		usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount		shares
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent		usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod		shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod		shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56148
	dei	Entity Registrant Name EntityRegistrantName	TRAQIQ, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CA
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	30-0580318
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1931 Austin Drive Troy
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MI
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	48083
	dei	City Area Code CityAreaCode	(425)
	dei	Local Phone Number LocalPhoneNumber	818-0560
	dei	Security12g Title Security12gTitle	Common Stock, $.0001 par value per share
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15134545	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	236815	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26650	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	885628	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	517583	usd
CY2022Q4	TRIQ	Subscription Receivable SubscriptionReceivable	200000	usd
CY2023Q2	us-gaap	Other Receivables OtherReceivables	11763	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	1241	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	194087	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	128689	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	455088	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	1783381	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	874163	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5626744	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5643941	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11192378	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	687500	usd
CY2023Q2	us-gaap	Goodwill Goodwill	6650621	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8251	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8251	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1717736	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	194112	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	25195730	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	6533804	usd
CY2023Q2	us-gaap	Assets Assets	26979111	usd
CY2022Q4	us-gaap	Assets Assets	7407967	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2455803	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	736658	usd
CY2023Q2	TRIQ	Customer Deposits CustomerDeposits	312544	usd
CY2023Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	192995	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	50983	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	209519	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	349651	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	95243	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	10890819	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1981042	usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	2539824	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	2785531	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1437237	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	115290	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3977061	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2900821	usd
CY2023Q2	us-gaap	Liabilities Liabilities	14867880	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4881863	usd
CY2022Q4	TRIQ	Member Equity MemberEquity	2526104	usd
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34252778	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34252778	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	0	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	3425	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35676238	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23568649	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	12111231	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2526104	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26979111	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7407967	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2961572	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1569853	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1827245	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	919738	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2741058	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1650046	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	1544103	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	917209	usd
	us-gaap	Gross Profit GrossProfit	220514	usd
	us-gaap	Gross Profit GrossProfit	-80193	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	283142	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	2529	usd
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	618647	usd
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	204374	usd
CY2023Q2	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	429330	usd
CY2022Q2	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	107390	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5588207	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	5588207	usd
	us-gaap	Professional Fees ProfessionalFees	924671	usd
	us-gaap	Professional Fees ProfessionalFees	23447	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	729892	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	7817	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	248540	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	241665	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	414052	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	124847	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	282401	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	62564	usd
	us-gaap	Operating Expenses OperatingExpenses	7794117	usd
	us-gaap	Operating Expenses OperatingExpenses	352668	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	7271496	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	177771	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7573603	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-432861	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6988354	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-175242	usd
	TRIQ	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	9652	usd
CY2023Q2	TRIQ	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	9652	usd
	us-gaap	Interest Expense Other InterestExpenseOther	438832	usd
	us-gaap	Interest Expense Other InterestExpenseOther	74610	usd
CY2023Q2	us-gaap	Interest Expense Other InterestExpenseOther	359180	usd
CY2022Q2	us-gaap	Interest Expense Other InterestExpenseOther	43056	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	103421	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	660837	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	103121	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-122463	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	15669287	usd
CY2023Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	15669287	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15995046	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	586227	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15915694	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-165519	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23568649	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	153366	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22904048	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-340761	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23568649	usd
	us-gaap	Net Income Loss NetIncomeLoss	153366	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-22904048	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-340761	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.69
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.69
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.67
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.67
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33959755	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33959755	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33959755	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33959755	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2526104	usd
CY2023Q1	TRIQ	Stock Issued During Period Value Settlement Of Note Due To Contribution StockIssuedDuringPeriodValueSettlementOfNoteDueToContribution	170000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-664601	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2031503	usd
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	300000	shares
CY2023Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	27395569	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5588207	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-22904048	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	12111231	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2038379	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	494127	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-1544252	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-1544252	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-340761	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-340761	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-1885013	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-1885013	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23568649	usd
	us-gaap	Net Income Loss NetIncomeLoss	153366	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	15669287	usd
	TRIQ	Employee Retention Credit EmployeeRetentionCredit	422845	usd
	TRIQ	Forgiveness Of Debt ForgivenessOfDebt	-91804	usd
	TRIQ	Forgiveness Of Debt ForgivenessOfDebt	-812305	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5588207	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	368556	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	134420	usd
	TRIQ	Change In Fair Value Of Derivative Liability And Derivative Expense ChangeInFairValueOfDerivativeLiabilityAndDerivativeExpense	9652	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	80281	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-151767	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1293	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-21487	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-200000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	47583	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	39860	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	10522	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	88777	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	39042	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1000	usd
	TRIQ	Increase Decrease In Right Of Use Assets IncreaseDecreaseInRightOfUseAssets	-111711	usd
	TRIQ	Increase Decrease In Right Of Use Assets IncreaseDecreaseInRightOfUseAssets	-40323	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	919472	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	160201	usd
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	1000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	120935	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	14207	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-58980	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-41718	usd
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	1198284	usd
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	66863	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-765490	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	116956	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-69104	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	173626	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1347989	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	281819	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-104522	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1066170	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	980000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	62003	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	300000	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	653470	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	259000	usd
	TRIQ	Repayments Of Note Payables Related Parties RepaymentsOfNotePayablesRelatedParties	-73780	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1348157	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	791290	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	326484	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1080177	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1206893	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	210165	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	257679	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26650	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	33579	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	236815	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	291258	usd
	us-gaap	Interest Paid Net InterestPaidNet	227590	usd
	us-gaap	Interest Paid Net InterestPaidNet	64101	usd
	TRIQ	Noncash Transactions Related To Reverse Acquisition NoncashTransactionsRelatedToReverseAcquisition	27162222	usd
	TRIQ	Settlement Of Note Payable SettlementOfNotePayable	170000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_801_eus-gaap--NatureOfOperations_zOKAFcQ5a3t" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_827_zABjk74KxH4f">ORGANIZATION AND NATURE OF OPERATIONS </span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TraQiQ, Inc. (“TraQiQ” or along with its wholly owned subsidiaries, referred to herein as the “Company”) is engaged in the full-service solution of waste management. The Company is based out of Troy, Michigan and offers a comprehensive package of waste reduction, collection, recycling, and technology-enabled solutions to support customer demand. The Company operates two distinct lines of business. The Company’s wholly-owned subsidiary, Titan Trucking, LLC (“Titan”), is a non-hazardous solid waste management company providing waste and recycling collection and transportation services for industrial generators, commercial contractors and transfer station operators in Michigan. Titan maintains a fleet of roll off and tractor trailer trucks to perform its services. The Company’s wholly-owned subsidiary Recoup Technologies, Inc. (“Recoup”), provides technology-enabled solutions for food waste processing, including onsite digestors for food waste along with cloud-based software tracking and analytics solutions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 19, 2023, the Company completed its acquisition of Titan and Titan’s wholly owned subsidiary, Senior Trucking, LLC (“Senior”). In accordance with ASC 805 - <i>Business Combinations </i>(“ASC 805”)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,</span> the transaction was treated as a reverse acquisition for financial reporting purposes, with TraQiQ treated as the legal acquirer and Titan treated as the accounting acquirer. TraQiQ remains the continuing registrant and reporting company . Accordingly, the historical financial and operating data of the Company, which covers periods prior to the closing date of the Titan Merger, reflects the assets, liabilities, and results of operations for Titan and does not reflect the assets, liabilities and results of operations of TraQiQ for the periods prior to May 19, 2023 (Note 3 – Business Combinations).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>March 31, 2023 Financial Statements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the preparation of the Company’s condensed consolidated financial statements, (collectively, “the financial statements”) as of June 30, 2023, the Company identified errors in its previously-issued financial statements as of and for the period ending March 31, 2023. Management determined that these financial statements incorrectly accounted for the January 5, 2023, acquisition of the Recoup digester business assets as a business combination instead of as an asset acquisition under the guidance enumerated in FASB ASC 805. The result of the change was to remove goodwill previously recorded ($<span id="xdx_908_eus-gaap--Goodwill_iI_pn5n6_c20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zqcSDhUVPGge" title="Goodwill">7.2</span> million) as part of the transaction and allocate that value to the intellectual property intangible asset. The Company also determined that the Black-Scholes model used to previously value the derivative liability was not appropriate and subsequently utilized a Monte Carlo pricing model, to more appropriately reflect the variability in the derivative. This resulted in a $<span id="xdx_90C_eus-gaap--DerivativeLiabilities_iI_pn6n6_c20230331__srt--RestatementAxis__srt--RestatementAdjustmentMember_zDGpiEMxTS47" title="Derivative liability">112</span> million reduction of the derivative liability at March 31, 2023. The Company’s management and the audit committee of the Company’s Board of Directors concluded that due to the correction of the errors that were discovered, the previously issued unaudited financial statements and other financial information contained in the Company’s Quarterly Reports on Forms 10-Q for the fiscal period ended March 31, 2023 should no longer be relied upon.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s acquisition of Titan on May 19, 2023 (Note 3 – Business Combinations) (the “Titan Merger”) was treated as a reverse acquisition under ASC 805 for financial reporting purposes, with TraQiQ as the legal acquirer and Titan as the accounting acquirer. Titan’s historical consolidated financial statements have replaced TraQiQ’s historical consolidated financial statements with respect to periods prior to the completion of the Titan Merger. Therefore, management believes the accounting errors identified do not impact the historical consolidated financial statements presented herein.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Going Concern</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s consolidated financial statements as of June 30, 2023 and December 31, 2022 are prepared using accounting principles generally accepted in the United States of America (“GAAP”), which contemplates continuation of the Company as a going concern. This contemplates the realization of assets and liquidation of liabilities in the ordinary course of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the six months ended June 30, 2023, the Company had a net loss of $<span id="xdx_905_eus-gaap--NetIncomeLoss_iN_di_c20230101__20230630_zV8FOdfIqIld" title="Net income loss">23,568,649</span>.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The working capital of the Company was a deficit of $<span id="xdx_903_ecustom--WorkingCapitalDeficit_iI_c20230630_zb6RRWh9QVIi">9,107,438</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of June 30, 2023 (deficit of $<span id="xdx_90D_ecustom--WorkingCapitalDeficit_iI_c20221231_zIpO0PHWHnyg" title="Working capital">1,106,879</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2022). These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after that date that the financial statements are issued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management’s plans include raising capital through issuances of equity and debt securities, and minimizing operating expenses of the business to improve the Company’s cash burn rate. In July 2023, the Company converted $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20230731_zBJYldu3oQc1" title="Principal amount">1,944,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of principal and $<span id="xdx_90D_eus-gaap--InterestExpense_c20230701__20230731__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_ztd1XGpR1zPi" title="Accrued interest">126,323 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of accrued interest related to its outstanding convertible note payables into common stock, resulting in the extinguishment of almost all of the Company’s convertible note embedded derivative liabilities (Note 16 – Subsequent Events). In addition, the Company has been successful in attracting substantial capital from investors interested in the current public status of the Company that has been used to support its ongoing cash outlays (Note 16 – Subsequent Events). The Company believes, but cannot guarantee, it will continue to be able to attract capital from outside sources as it pursues a move to a national stock exchange. The Company has engaged a qualified investment bank to assist in the uplisting of its common stock and simultaneous raise of capital. In addition, the Company’s revenue continues to grow and management expects the Company to shrink its net losses over the upcoming quarters through organic and acquisitive growth. The Company has identified a plan to decrease expenses going forward to reduce its cash burn.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Net Income Loss NetIncomeLoss	-23568649	usd
CY2023Q2	TRIQ	Working Capital Deficit WorkingCapitalDeficit	9107438	usd
CY2022Q4	TRIQ	Working Capital Deficit WorkingCapitalDeficit	1106879	usd
CY2023Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1944000	usd
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	70997	usd
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	0	usd
CY2023Q2	us-gaap	Notes Payable NotesPayable	642654	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_zFCkr8ECwuy8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zmY7NPM9SvVg">Accounting Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	77690	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	77690	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	93744	usd
CY2022Q4	TRIQ	Subscription Receivable SubscriptionReceivable	200000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	15669287	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zpJ52LI9z4T2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zP2BRooZPCa1">Concentration Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company performs a regular review of customer activity and associated credit risks.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, two customers accounted for approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--TwoCustomerAMember_zgbJF1ADtkfe" title="Concentration risk, percentage">43</span>% of accounts receivable. As of December 31, 2022, one customer accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--OneCustomerAMember_zKmGs33CBIFg" title="Concentration risk, percentage">63</span>% of accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the six months ended June 30, 2023, one customer accounted for approximately <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneCustomerAMember_zTS1pS6yfPN6" title="Concentration risk, percentage">42</span>% of total revenues generated. During the six months ended June 30, 2022, one customer accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneCustomerAMember_ztJz3ppBE3bb" title="Concentration risk, percentage">55</span>% of total revenues generated. During the three months ended June 30, 2023, one customer accounted for approximately <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneCustomerAMember_zGKFqRl7G5ek" title="Concentration risk, percentage">34</span>% of total revenues generated. During the three months ended June 30, 2022, one customer accounted for approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneCustomerAMember_ztcbTw0i1a2c" title="Concentration risk, percentage">53</span>% of total revenues generated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains positive customer relationships and continually expands its customer base, mitigating the impact of any potential concentration risks that exist.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	286169098	shares
	us-gaap	Interest Expense Debt InterestExpenseDebt	78391	usd
CY2022Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	46838	usd
CY2023Q2	TRIQ	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Unreleased In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndUnreleasedInPeriod	1405000	shares
CY2023Q2	TRIQ	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Vested And Unreleased In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueVestedAndUnreleasedInPeriod	0.01
CY2023Q2	TRIQ	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Unvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsUnvestedNumber	3600000	shares
CY2023Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	12560	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	13908	usd
CY2022Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1209	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1654	usd
CY2023Q2	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	2967	usd
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	5825	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	184175	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	85587	usd
	TRIQ	Business Acquisition Proforma Weighted Average Number Of Shares Outstanding Diluted BusinessAcquisitionProformaWeightedAverageNumberOfSharesOutstandingDiluted	33959755	shares
CY2022	TRIQ	Business Acquisition Proforma Weighted Average Number Of Shares Outstanding Diluted BusinessAcquisitionProformaWeightedAverageNumberOfSharesOutstandingDiluted	4410595	shares
CY2022	TRIQ	Share Based Compensation Pro Forma ShareBasedCompensationProForma	5608000	usd
CY2022	TRIQ	Goodwill Impairment Loss Pro Forma GoodwillImpairmentLossProForma	15669287	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6916427	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6741605	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1289683	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1097664	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5626744	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5643941	usd
CY2023Q2	us-gaap	Depreciation Depreciation	97162	usd
	us-gaap	Depreciation Depreciation	191956	usd
CY2022Q2	us-gaap	Depreciation Depreciation	67372	usd
	us-gaap	Depreciation Depreciation	134420	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	176599	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11192378	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	687500	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11192378	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	687500	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	176599	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	169724	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	597597	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1188698	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1185450	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1185450	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1185450	usd
CY2023Q2	TRIQ	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	5849733	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11192378	usd
CY2022Q2	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	2875	usd
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	5398	usd
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	2020250	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	669231	usd
CY2023Q2	TRIQ	Credit Card Payable CreditCardPayable	160767	usd
CY2022Q4	TRIQ	Credit Card Payable CreditCardPayable	29454	usd
CY2023Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	122886	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	12298	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	151900	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	25675	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	2455803	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	736658	usd
CY2023Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P12M
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y5M15D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y29D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0792	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0757	pure
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	TRIQ	Member Equity MemberEquity	2526104	usd
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34252778	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34252778	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	229096	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	508481	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	421498	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	427670	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	443707	usd
CY2023Q2	TRIQ	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	112968	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2143420	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	356532	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1786888	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	349651	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1437237	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	152333	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	50745	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	124780	usd
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	25879	usd
CY2023Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	4558106	usd
CY2023Q2	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	2603126	usd
CY2022Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	1118605	usd
CY2022Q4	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	2858828	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	25936	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	63302	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	20447	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	73297	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	4532170	usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	2539824	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1098158	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	2785531	usd
CY2023Q2	TRIQ	Notes Payable Including Related Party Current NotesPayableIncludingRelatedPartyCurrent	3878700	usd
CY2023Q2	TRIQ	Notes Payable Including Related Party Non Current NotesPayableIncludingRelatedPartyNonCurrent	2539824	usd
CY2022Q4	TRIQ	Notes Payable Including Related Party Current NotesPayableIncludingRelatedPartyCurrent	1098158	usd
CY2022Q4	TRIQ	Notes Payable Including Related Party Non Current NotesPayableIncludingRelatedPartyNonCurrent	2785531	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	213720	usd
CY2023Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	136367	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	209519	usd
	TRIQ	Warrants Conversion Option Derivative Liabilities Recognized Due To Reverse Acquisition WarrantsConversionOptionDerivativeLiabilitiesRecognizedDueToReverseAcquisition	219172	usd
	TRIQ	Derivative Gain Loss On Derivative DerivativeGainLossOnDerivative	-9652	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	209519	usd
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	22500	usd
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.50	pure
	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	1	pure
CY2023Q2	TRIQ	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Unvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueUnvestedNumber	0.01
CY2023Q2	TRIQ	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Unvested Number Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingUnvestedNumberContractualTerms	P2Y7M13D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	600000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	0.01
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3000000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.01
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P1Y11M12D
CY2023Q2	TRIQ	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Unreleasef In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndUnreleasefInPeriod	2005000	shares
CY2023Q2	TRIQ	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Vested And Unreleasef In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueVestedAndUnreleasefInPeriod	0.01
CY2023Q2	TRIQ	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedOutstandingNumber	5005000	shares
CY2023Q2	TRIQ	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageGrantDateFairValue	0.01
CY2023Q2	TRIQ	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Outstanding Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageRemainingContractualTerm	P2Y6M3D
CY2023Q2	TRIQ	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Unreleasef In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndUnreleasefInPeriod	2005000	shares
CY2023Q2	TRIQ	Stock Issued During Period Shares Restricted Stock Award Vested Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardVestedForfeited	1705000	shares
CY2023Q2	TRIQ	Stock Issued During Period Shares Restricted Stock Award Unvested Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardUnvestedForfeited	3000000	shares
CY2023Q2	TRIQ	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Unreleased In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndUnreleasedInPeriodFairValue	16439	usd

Files In Submission

Name	View Source	Status
triq-20230630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001493152-23-036485-index-headers.html	Edgar Link	pending
0001493152-23-036485-index.html	Edgar Link	pending
0001493152-23-036485.txt	Edgar Link	pending
0001493152-23-036485-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
triq-20230630.xsd	Edgar Link	pending
triq-20230630_pre.xml	Edgar Link	unprocessable
triq-20230630_lab.xml	Edgar Link	unprocessable
triq-20230630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TESI
Titan Environmental Solutions Inc Stock $tesi

2023 Q4 Form 10-Q Financial Statement

#000149315223036485 Filed on October 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TESI Titan Environmental Solutions Inc Stock $tesi

2023 Q4 Form 10-Q Financial Statement

#000149315223036485 Filed on October 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TESI
Titan Environmental Solutions Inc Stock $tesi